Chinese drug aims at taming HIV/AIDS related complications

NAIROBI, KENYA: As the countdown to World Aids Day to be observed next week gets closer, a Chinese researcher invention of popular herbal concoction has gained recognition as solution to HIV/AIDS and related complications such as TB.

Professor Tian Shengxun invented Tian Immunity Booster (TIB), as new approach to effective support to   those infected and affected by HIV/ Aids. The therapy is the first oral Fusion Inhibitor drug in the world so far for one of the global health disasters of the century.  The therapy has been clinically used for HIV/AIDS for the past almost 25 years mainly in Africa and Asia, it is expected to make it available on European market by the future.

According to Prof. Shengxun, as alternative HIV/AIDS therapy, patients using TIB can survive for more than 05, 10 or 15 years respectively.    Studies conducted on TIB by Dr. Josef Schneider at Freiburg University (Germany) and similar study by Dr Peter Nara of Biological Mimetics Inc in Maryland State (USA) reveal the drug can inhibit the replication of HIV. At the same time the laboratory assays also have been carried out in UK and Japan.